Chenoweth M R, Somerville G A, Krause D C, O'Reilly K L, Gherardini F C
Laboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana 59840, USA.
Appl Environ Microbiol. 2004 Feb;70(2):656-63. doi: 10.1128/AEM.70.2.656-663.2004.
Bartonella henselae is a zoonotic pathogen that usually causes a self-limiting infection in immunocompetent individuals but often causes potentially life-threatening infections, such as bacillary angiomatosis, in immunocompromised patients. Both diagnosis of infection and research into the molecular mechanisms of pathogenesis have been hindered by the absence of a suitable liquid growth medium. It has been difficult to isolate B. henselae directly from the blood of infected humans or animals or to grow the bacteria in liquid culture media under laboratory conditions. Therefore, we have developed a liquid growth medium that supports reproducible in vitro growth (3-h doubling time and a growth yield of approximately 5 x 10(8) CFU/ml) and permits the isolation of B. henselae from the blood of infected cats. During the development of this medium, we observed that B. henselae did not derive carbon and energy from the catabolism of glucose, which is consistent with genome nucleotide sequence data suggesting an incomplete glycolytic pathway. Of interest, B. henselae depleted amino acids from the culture medium and accumulated ammonia in the medium, an indicator of amino acid catabolism. Analysis of the culture medium throughout the growth cycle revealed that oxygen was consumed and carbon dioxide was generated, suggesting that amino acids were catabolized in a tricarboxylic acid (TCA) cycle-dependent mechanism. Additionally, phage particles were detected in the culture supernatants of stationary-phase B. henselae, but not in mid-logarithmic-phase culture supernatants. Enzymatic assays of whole-cell lysates revealed that B. henselae has a complete TCA cycle. Taken together, these data suggest B. henselae may catabolize amino acids but not glucose to derive carbon and energy from its host. Furthermore, the newly developed culture medium should improve isolation of B. henselae and basic research into the pathogenesis of the bacterium.
亨氏巴尔通体是一种人畜共患病原体,通常在免疫功能正常的个体中引起自限性感染,但在免疫功能低下的患者中常引起潜在的危及生命的感染,如杆菌性血管瘤病。由于缺乏合适的液体生长培养基,感染的诊断和发病机制的分子机制研究均受到阻碍。直接从受感染的人类或动物血液中分离亨氏巴尔通体,或在实验室条件下在液体培养基中培养该细菌一直很困难。因此,我们开发了一种液体生长培养基,该培养基支持可重复的体外生长(3小时倍增时间和约5×10⁸CFU/ml的生长产量),并允许从受感染猫的血液中分离亨氏巴尔通体。在这种培养基的开发过程中,我们观察到亨氏巴尔通体不能从葡萄糖的分解代谢中获取碳和能量,这与基因组核苷酸序列数据一致,表明其糖酵解途径不完整。有趣的是,亨氏巴尔通体从培养基中消耗氨基酸并在培养基中积累氨,这是氨基酸分解代谢的一个指标。对整个生长周期的培养基分析表明,氧气被消耗,二氧化碳产生,这表明氨基酸是以三羧酸(TCA)循环依赖机制进行分解代谢的。此外,在亨氏巴尔通体稳定期的培养上清液中检测到噬菌体颗粒,但在对数中期培养上清液中未检测到。全细胞裂解物的酶活性测定表明亨氏巴尔通体具有完整的TCA循环。综上所述,这些数据表明亨氏巴尔通体可能分解代谢氨基酸而非葡萄糖以从其宿主获取碳和能量。此外,新开发的培养基应能改善亨氏巴尔通体的分离及对该细菌发病机制的基础研究。